Our Department

Department Alumni Fest 2016

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

Publications by Paul Gustafson


Falasinnu T, Gilbert M, Gustafson P, Shoveller J. A validation study of a clinical prediction rule for screening asymptomatic chlamydia and gonorrhoea infections among heterosexuals in British Columbia. Sexually transmitted infections. BMJ Publishing Group Ltd; 2016;92:12–18.
Xia M, Gustafson P. Bayesian regression models adjusting for unidirectional covariate misclassification. Canadian Journal of Statistics. 2016;44:198–218.
Falasinnu T, Gilbert M, Gustafson P, Shoveller J. An assessment of population-based screening guidelines versus clinical prediction rules for chlamydia and gonorrhea case finding. Preventive medicine. Academic Press; 2016;89:51–56.
Zhang T, Kingwell E, De Jong HJI, Zhu F, Zhao Y, Carruthers R, et al. Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression. Pharmacoepidemiology and Drug Safety. 2016;.
Goring SM, Gustafson P, Liu Y, Saab S, Cline SK, Platt RW. Disconnected by design: analytic approach in treatment networks having no common comparator. Research synthesis methods. Wiley Online Library; 2016;.


Gustafson P. Discussion of ``On Bayesian Estimation of Marginal Structural Models''. Biometrics. Wiley-Blackwell; 2015;71:291–293.
Etminan M, Luo H, Gustafson P. Risk of intracranial hypertension with intrauterine levonorgestrel. Therapeutic advances in drug safety. SAGE Publications; 2015;6:110–113.
Shirani A, Zhao Y, Petkau J, Gustafson P, Karim MEhsanul, Evans C, et al. Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment. BioMed research international. Hindawi Publishing Corporation; 2015;2015.
Zhang T, Shirani A, Zhao Y, Karim ME, Gustafson P, Petkau J, et al. Beta-interferon exposure and onset of secondary progressive multiple sclerosis. European Journal of Neurology. Wiley Online Library; 2015;22:990–1000.


Evans C, Zhu F, Kingwell E, Shirani A, Kop ML, Petkau J, et al. Association between beta-interferon exposure and hospital events in multiple sclerosis. Pharmacoepidemiology and drug safety. Wiley Online Library; 2014;23:1213–1222.
Falasinnu T, Gustafson P, Hottes TSalway, Gilbert M, Ogilvie G, Shoveller J. A critical appraisal of risk models for predicting sexually transmitted infections. Sexually transmitted diseases. LWW; 2014;41:321–330.
Wang D, Gustafson P. On the Impact of Misclassification in an Ordinal Exposure Variable. Epidemiologic Methods. 2014;3:97–106.
Shirani A, Zhao Y, Karim ME, Petkau J, Gustafson P, Evans C, et al. Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study. European Journal of Neurology. Wiley Online Library; 2014;21:835–844.
Falasinnu T, Gilbert M, Gustafson P, Shoveller J. Deriving and validating a risk estimation tool for screening asymptomatic chlamydia and gonorrhea. Sexually transmitted diseases. LWW; 2014;41:706–712.
Xia M, Gustafson P. Bayesian sensitivity analyses for hidden sub-populations in weighted sampling. Canadian Journal of Statistics. Wiley Online Library; 2014;42:436–450.
Karim MEhsanul, Gustafson P, Petkau J, Zhao Y, Shirani A, Kingwell E, et al. Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort. American journal of epidemiology. Oxford University Press; 2014;180:160–171.
Gustafson P, Greenland S. Misclassification. In Handbook of Epidemiology. Springer; 2014. pp. 639–658.
Falasinnu T, Gilbert M, Salway THottes, Gustafson P, Ogilvie G, Shoveller J. Predictors identifying those at increased risk for STDs: a theory-guided review of empirical literature and clinical guidelines. International journal of STD & AIDS. SAGE Publications; 2014;:0956462414555930.
Sighoko D, Liu J, Hou N, Gustafson P, Huo D. Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?. The oncologist. AlphaMed Press; 2014;19:592–601.
Gustafson P, McCandless L. Commentary: Priors, Parameters, and Probability: A Bayesian Perspective on Sensitivity Analysis. Epidemiology. LWW; 2014;25:910–912.
Gustafson P. Bayesian Statistical Methodology for Observational Health Sciences Data. Statistics in Action: A Canadian Outlook. CRC Press; 2014;:163.


Shirani A, Zhao Y, Karim MEhsanul, Evans C, Kingwell E, van der Kop ML, et al. Interferon beta and long-term disability in multiple sclerosis. JAMA neurology. American Medical Association; 2013;70:651–653.
Gustafson P. Bayesian Analysis of Frailty Models. Handbook of Survival Analysis. CRC Press; 2013;:475.
Falasinnu T, Gustafson P, Gilbert M, Shoveller J. Risk prediction in sexual health contexts: Protocol. JMIR research protocols. JMIR Publications Inc.; 2013;2.
Gustafson P, Gilbert M, Xia M, Michelow W, Robert W, Trussler T, et al. Impact of Statistical Adjustment for Frequency of Venue Attendance in a Venue-based Survey of Men Who Have Sex With Men. American Journal of Epidemiology. Oxford University Press; 2013;177:1157–1164.
Xing L, Burstyn I, Richardson DB, Gustafson P. A comparison of Bayesian hierarchical modeling with group-based exposure assessment in occupational epidemiology. Statistics in medicine [Internet]. Wiley Online Library; 2013;. http://onlinelibrary.wiley.com/doi/10.1002/sim.5791/abstract
Burstyn I, de Vocht F, Gustafson P. What do measures of agreement ($ąppa$) tell us about quality of exposure assessment? Theoretical analysis and numerical simulation. BMJ open. British Medical Journal Publishing Group; 2013;3:e003952.
Luo H, Burstyn I, Gustafson P. Investigations of Gene-Disease Associations: Costs and Benefits of Environmental Data. Epidemiology. LWW; 2013;24:562–568.


MacLehose RF, Gustafson P. Is probabilistic bias analysis approximately Bayesian?. Epidemiology [Internet]. 2012;23:151. 10.1097/EDE.0b013e31823b539c
McCandless LC, Gustafson P, Levy AR, Richardson S. Hierarchical priors for bias parameters in Bayesian sensitivity analysis for unmeasured confounding. Statistics in Medicine. 2012;31:383–396.
Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, et al. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA: The Journal of the American Medical Association [Internet]. American Medical Association; 2012;308:247–256. http://jama.jamanetwork.com/article.aspx?articleid=1217239
Gustafson P. Double-robust estimators: Slightly more Bayesian than meets the eye?. International Journal of Biostatistics. 2012;8:issue 2, article 4.
Gustafson P. On the behaviour of Bayesian credible intervals in partially identified models. Electronic Journal of Statistics [Internet]. 2012;6:2107-2124. projecteuclid.org/euclid.ejs/1351865119
Xia M, Gustafson P. A Bayesian method for estimating prevalence in the presence of a hidden sub-population. Statistics in Medicine. Wiley Online Library; 2012;31:2386–2398.
Gustafson P. Double-robust estimators: slightly more Bayesian than meets the eye?. The international journal of biostatistics. 2012;8:1–15.
Liu J, Gustafson P. On the detectability of different forms of interaction in regression models. Metrika. Springer; 2012;75:347–365.


Gustafson P. Comment on `Transparent parameterizations of models for potential outcomes,' by Richardson, Evans, and Robins. In: Bernardo JM, Bayarri MJ, Berger JO, Dawid AP, Heckerman D, Smith AFM, et al. Bayesian Statistics 9: Proceedings of the Ninth Valencia International Meeting. Oxford University Press; 2011.
Gustafson P. Discussion of" Bayesian local influence for survival models," by Ibrahim, Zhu, and Tang. Lifetime data analysis. Springer Science & Business Media; 2011;17:71.
Liu J, Gustafson P. Regression with fractional polynomials when interactions are erroneously omitted. Journal of Statistical Planning and Inference. Elsevier; 2011;.
Espino-Hernandez G, Gustafson P, Burstyn I. Bayesian adjustment for measurement error in continuous exposures in an individually matched case-control study. BMC Medical Research Methodology [Internet]. BioMed Central Ltd; 2011;11:67. http://www.biomedcentral.com/1471-2288/11/6